Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Acq. announced
Appointed director
Quarterly results

Diffusion Pharmaceuticals Inc. (DFFN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/02/2022 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
08/06/2019 4/A Adams Robert W (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns: Granted 19,200 options to buy @ $3.15, valued at $60.5k
08/06/2019 4/A Giles Mark T (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns: Granted 19,200 options to buy @ $3.15, valued at $60.5k
08/06/2019 4/A LEVIN ALAN G (Director) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns: Granted 19,200 options to buy @ $3.15, valued at $60.5k
06/30/2017 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
06/30/2017 4/A Gainer John (Chief Scientific Officer) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns: Granted 34,000 options to buy @ $2.96, valued at $100.6k
06/30/2017 4/A Shealy Ben (Sr VP Finance & Treasurer) has filed a Form 4 on Diffusion Pharmaceuticals Inc.
Txns: Granted 23,100 options to buy @ $2.96, valued at $68.4k
06/19/2014 4/A BARER SOL J (Chairman of the Board) has filed a Form 4 on RestorGenex Corp
Txns: Converted 270,616 shares @ $2, valued at $541.2k
Converted 78,473 shares @ $2, valued at $156.9k
Converted 76,755 shares @ $2, valued at $153.5k
Converted 126,894 shares @ $2, valued at $253.8k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy